Clinical Trial Update: Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating LCZ696 (sacubitril/valsartan) and valsartan in Asian patients with Salt-sensitive Hypertension. The study has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salt-sensitive Hypertension

Drugs mentioned

• LCZ696 (sacubitril/valsartan)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Salt-sensitive Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-10-09